CVS Health Corporation

CVS Health Corporation

79.96
USD
-11.45
(-12.53%)
3.82EPS
26.93P/E
132.21BMarket Cap
Feb 17Next Earn
CVS Health Corporation
NYSE:CVS
(New York Stock Exchange)

Recent

price

79.96

P/E

ratio

26.93

div

yld

3.36%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
70.06
80.03
96.87
104.16
120.04
137.11
165.47
181.16
186.38
197.37
205.28
221.46
245.78
278.42
296.12
317.34
326.13
Revenue per Share
2.51
2.59
3.04
3.77
4
4.68
4.96
6.49
-0.57
5.1
5.48
6.07
3.29
6.49
3.66
1.4
3.84
Basic EPS, GAAP
2.03
2.98
3.65
3.12
5.17
5.52
7.38
5.97
6.54
7.99
10.26
11.94
10.25
8.09
5.02
6.16
9.24
Free Cash Flow per Basic Share
0.35
0.5
0.65
0.9
1.11
1.41
1.71
2.01
1.95
2
2
1.99
2.22
2.44
2.68
2.68
2.68
Dividend per Share
27.66
29.29
30.59
32.15
33.3
33.78
34.71
37.17
44.96
49.05
52.97
56.79
54.98
59.36
59.97
59.18
62.36
Book Value per Share
1.65
1.31
1.22
1.58
0.04
-13.43
-14.07
-14.19
-44
-37.64
-31.53
-25.02
-24.22
-34.2
-34.15
-28.14
-23.8
Tangible Book Value per Share
1,367
1,338
1,271
1,217
1,161
1,118
1,073
1,020
1,044
1,301
1,309
1,319
1,312
1,285
1,259
1,267
1,273
Basic Weighted Avg Shares
95,778
107,080
123,120
126,761
139,367
153,290
177,546
184,786
194,579
256,776
268,706
292,111
322,467
357,776
372,809
402,067
415,086
Sales/Revenue/Turnover
6.41
5.91
5.86
6.34
6.31
6.18
5.85
5.26
5.23
4.76
5.18
5.17
5.05
4.08
2.6
2.58
3.38
Operating Margin (%)
1,469
1,568
1,753
1,870
1,931
2,092
2,475
2,479
2,718
4,371
4,441
4,486
4,224
4,366
4,597
4,606
4,522
Depreciation Expense
3,427
3,462
3,864
4,592
4,644
5,237
5,317
6,622
-594
6,634
7,179
8,001
4,311
8,344
4,614
1,768
4,890
Net Income, GAAP
38.9
39.29
38.64
38.89
39.5
39.3
38.4
19.8
142.39
26.3
26.29
24.18
25.86
25.11
25.41
19.1
15.59
Effective Tax Rate (%)
3.58
3.23
3.14
3.62
3.33
3.42
2.99
3.58
-0.31
2.58
2.67
2.74
1.34
2.33
1.24
0.44
1.18
Profit Margin (%)
6,636
6,638
6,011
9,900
6,956
5,989
4,792
581
1,234
-3,001
-5,648
-7,799
-3,788
-11,331
-15,964
-13,978
-11,695
Working Capital
8,652
9,208
9,133
12,841
11,630
26,267
25,615
22,181
71,444
83,625
77,964
70,148
67,276
74,672
75,426
74,145
72,434
LT Debt
37,734
38,051
37,653
37,938
37,963
37,203
36,834
37,695
58,543
64,170
69,701
75,381
71,769
76,636
75,730
75,382
79,899
Total Equity
7.92
8.02
9.26
9.94
10.42
9.96
9.92
11.85
-1.73
6.2
6.66
6.59
4.01
6.9
4.04
2.4
4.42
Return on Invested Capital (%)
7.94
7.98
8.81
9.93
9.82
9.97
9.27
11.58
-1.73
6.22
6.05
6.48
4.08
6.91
4.35
2.76
4.75
Return on Capital (%)
9.33
9.14
10.21
12.15
12.24
13.94
14.37
17.77
-1.24
10.87
10.77
11.08
5.88
11.28
6.07
2.35
6.23
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,805
4,484
3,872
LT Borrowings
60,502
60,531
59,452
LT Finance Leases
13,643
13,330
12,982
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,271
1,273
1,278
Market Capitalization
100,867
91,427
132,209

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
74,714
74,817
75,346
Cash, Cash Equivalents & STI
10,598
11,802
13,958
Accounts Receivable, Net
16,316
20,144
19,380
Inventories
19,246
17,770
17,622
Total Current Liabilities
88,692
86,406
87,041
Payables & Accruals
81,771
80,847
82,160
ST Debt
5,805
4,484
3,872
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.34%
1.7%
-0.46%
Free Cash Flow
6.3%
-7.15%
23.41%
Net Income, GAAP
-133.9%
-9.5%
-61.68%
Sales/Revenue/Turnover
10.39%
8.42%
7.85%
Total Cash Common Dividend
8.3%
5.38%
0.71%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
88,437
91,234
95,428
97,710
372,809
2025
94,588
98,915
102,871
105,693
402,067
2026
100,426
106,096
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.88
1.41
0.07
1.31
3.66
2025
1.41
0.81
-3.13
2.32
1.4
2026
2.31
2.33
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.67
0.68
0.66
0.67
2.68
2025
0.67
0.68
0.67
0.67
2.68
2026
0.67
0.69
- -
- -
- -
Business
CVS Health Corporation (CVS) operates as a diversified health solutions provider, offering integrated pharmacy, health insurance, and care services across the United States through segments including Health Care Benefits via Aetna, Pharmacy Services via CVS Caremark, and retail pharmacy operations; core products and services encompass retail pharmacies with over 9,600 locations selling prescription drugs, over-the-counter medications, health and wellness products, and general merchandise; MinuteClinic walk-in clinics providing diagnostic testing, vaccinations, and primary care; pharmacy benefit management including formulary management, claims processing, mail-order and specialty pharmacy, infusion services, and long-term care pharmacy consulting; Aetna health insurance plans covering medical, pharmacy, dental, behavioral health, and Medicare options for employers, individuals, and government programs; CVS Specialty for complex chronic disease therapies; and digital tools like mobile apps for prescription management and virtual care. Founded in 1963 and headquartered in Woonsocket, Rhode Island, the company serves approximately 100 million consumers nationwide with a workforce exceeding 300,000 colleagues, focusing on underserved communities through in-home, in-store, and virtual services. Recent developments include the completion in October 2025 of its acquisition of select Rite Aid and Bartell Drugs assets, adding 63 stores in Idaho, Oregon, and Washington plus prescription files from 626 pharmacies across 15 states to expand access for over 9 million patients; an expanded partnership with a major insurer announced in November 2025 to enhance service integration; and ongoing investments in pharmacy workforce hiring and training amid strong third-quarter 2025 financial performance with raised full-year guidance.

Company News

  • CVS announces major breakup, pharmacy expert weighs impact on consumers

  • 48,865 Shares in CVS Health Corporation $CVS Bought by Associated Banc Corp

  • Inside CVS Health, a small group of top executives spent months engaged in a strategic review that developed into a secret plan: a decision to split up the $400 billion healthcare giant

  • Wednesday's Final Takeaways: CVS Splitting in Two, ORCL Scraps Tencent Deal

  • Stock Market Today, Nov. 4: Dow Surges 3% in Biggest Post-Midterm Rally in 44 Years

  • CVS is splitting into two companies: Healthcare giant's ‘Pharmacy' breakup explained

  • CVS Health plans to split itself up. Here's why a breakup could make sense now

  • CVS Dismantling Healthcare Empire: Regulatory Tailwinds v. Cost Headwinds

  • CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat; Elevance Health Rises 4%, Cigna Climbs 3%

  • Divided Government Sends the Dow Up 1000 Points

  • CVS Is Breaking Itself Up. Here's What That Means for Your Healthcare ETF

  • CVS Q3 Earnings & Revenues Top Estimates, Stock Up in Pre-Market

  • CVS Health Corporation (CVS) Q3 2026 Earnings Call Transcript

  • CVS Health (CVS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

  • Dow Futures Jump Over 1,100 Points After Blue Midterm Sweep

  • CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates

  • Hershey Trades 21% Below Its Historical P/E. Here Are 2 More Dividend Stocks

  • CVS Health plans to split in two. Here's what is driving the massive healthcare breakup.

  • CVS Is Reportedly Breaking Itself in Two

  • CVS Raises Forecast on Health Care Benefits, Pharmacy Gains